306 related articles for article (PubMed ID: 16474912)
1. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.
Yoon SS; Kim SH; Gonen M; Heffernan NM; Detwiller KY; Jarnagin WR; D'Angelica M; Blumgart LH; Tanabe KK; Dematteo RP
Ann Surg Oncol; 2006 Mar; 13(3):353-62. PubMed ID: 16474912
[TBL] [Abstract][Full Text] [Related]
2. Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.
Osada S; Matsui S; Komori S; Yamada J; Sanada Y; Ihawa A; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Hosono Y; Takahashi T; Yamaguchi K; Yoshida K
Hepatogastroenterology; 2010; 57(97):76-80. PubMed ID: 20422876
[TBL] [Abstract][Full Text] [Related]
3. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
[TBL] [Abstract][Full Text] [Related]
4. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
[TBL] [Abstract][Full Text] [Related]
5. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor.
de Jong KP; Hoedemakers RM; Fidler V; Bijzet J; Limburg PC; Peeters PM; de Vries EG; Slooff MJ
Scand J Gastroenterol; 2004 Nov; 39(11):1141-8. PubMed ID: 15545174
[TBL] [Abstract][Full Text] [Related]
6. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases.
Rahbari NN; Reissfelder C; Mühlbayer M; Weidmann K; Kahlert C; Büchler MW; Weitz J; Koch M
Ann Surg Oncol; 2011 Aug; 18(8):2182-91. PubMed ID: 21598056
[TBL] [Abstract][Full Text] [Related]
7. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
8. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
[TBL] [Abstract][Full Text] [Related]
9. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
[TBL] [Abstract][Full Text] [Related]
10. Increased growth factor expression after hepatic and pancreatic resection.
Justinger C; Schlüter C; Oliviera-Frick V; Kopp B; Rubie C; Schilling MK
Oncol Rep; 2008 Dec; 20(6):1527-31. PubMed ID: 19020737
[TBL] [Abstract][Full Text] [Related]
11. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.
Viganò L; Ferrero A; Lo Tesoriere R; Capussotti L
Ann Surg Oncol; 2008 Sep; 15(9):2458-64. PubMed ID: 18463927
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases.
Korita PV; Wakai T; Shirai Y; Sakata J; Takizawa K; Cruz PV; Ajioka Y; Hatakeyama K
Ann Surg Oncol; 2007 Dec; 14(12):3472-80. PubMed ID: 17828431
[TBL] [Abstract][Full Text] [Related]
14. Perioperative detection of circulating cancer cells in patients with colorectal hepatic metastases.
Uchikura K; Ueno S; Takao S; Miyazono F; Nakashima S; Tokuda K; Nakajo A; Matsumoto M; Aiko T
Hepatogastroenterology; 2002; 49(48):1611-4. PubMed ID: 12397747
[TBL] [Abstract][Full Text] [Related]
15. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases.
Bennett JJ; Schmidt CR; Klimstra DS; Grobmyer SR; Ishill NM; D'Angelica M; DeMatteo RP; Fong Y; Blumgart LH; Jarnagin WR
Ann Surg Oncol; 2008 Apr; 15(4):1130-6. PubMed ID: 18228106
[TBL] [Abstract][Full Text] [Related]
16. Solitary colorectal liver metastasis: resection determines outcome.
Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
[TBL] [Abstract][Full Text] [Related]
17. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume.
Davies MM; Jonas SK; Kaur S; Allen-Mersh TG
Br J Cancer; 2000 Mar; 82(5):1004-8. PubMed ID: 10737380
[TBL] [Abstract][Full Text] [Related]
18. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
Shah SA; Haddad R; Al-Sukhni W; Kim RD; Greig PD; Grant DR; Taylor BR; Langer B; Gallinger S; Wei AC
J Am Coll Surg; 2006 Mar; 202(3):468-75. PubMed ID: 16500252
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases.
Pamecha V; Glantzounis G; Davies N; Fusai G; Sharma D; Davidson B
Ann Surg Oncol; 2009 May; 16(5):1202-7. PubMed ID: 19130138
[TBL] [Abstract][Full Text] [Related]
20. Surgical management for metastatic liver tumors.
Hirai I; Kimura W; Fuse A; Isobe H; Hachiya O; Moriya T; Suto K; Mizutani M
Hepatogastroenterology; 2006; 53(71):757-63. PubMed ID: 17086883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]